ArticleInvestigational new drugs2021

Helicobacter pylori infection as a potential favorable factor for immune checkpoint inhibitor therapy for gastric cancer.

Ming-Jun Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.